hat
Halotestin se yon C17-alpha alkylated (C17-aa) anabolizan esteroyid, ki refere a chanjman estriktirèl la nan pozisyon an kabòn 17th. Espesyalman, sa a refere a gwoup la methyl te ajoute nan pozisyon an kabòn 17th ki pwoteje òmòn lan nan enjèstyon oral. Pandan ke sa nesesè nan siviv òmòn lan, malerezman li lakòz li pote yon nati toksik. Nan tout oral C17-aa estewoy anabolizan, Halotestin pote youn nan nati yo hepatotoxik pi fò nan tout. Valè anzim Fwa yo ap ogmante ak itilizasyon sa a esteroyid, ak plis pase anpil chans anpil. Ogmantasyon valè anzim valè pa egal pou domaj, men se yon endikasyon estrès epi li ka yon endikatè fò nan domaj vini.
eng
Halotestin is a C17-alpha alkylated (C17-aa) anabolic steroid, which refers to the structural change at the 17th carbon position. Specifically, this refers to the added methyl group at the 17th carbon position that protects the hormone through oral ingestion. While necessary to the hormone’s survival, unfortunately it causes it to carry a toxic nature. Of all oral C17-aa anabolic steroids, Halotestin carries one of the strongest hepatotoxic natures of all. Liver enzyme values will increase with the use of this steroid, and more than likely substantially. Increased liver enzyme values does not equate to damage but is an indicator of stress and can be a strong indicator of damage to come.